An outpatient-based clinical program for diabetes prevention: An update

Endocrine Practice

Volumn 18, Issue 2, 2012, Pages 200-208

  Swanson, Christine M ^a   Bersoux, Sophie ^a   Larson, Marcia H ^a   Aponte Furlow, Ruth T ^a   Flatten, Sandra S ^a   Olsen, Cari L ^a   LaRosa, Carolyn ^b   Verona, Patricia M ^a   Jameson, Kimberly A ^a   Cook, Curtiss B ^a  

^a MAYO CLINIC   (United States)

^b HARVARD VANGUARD MEDICAL ASSOCIATES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ADULT; ARTICLE; DIABETES CONTROL; DIABETES MELLITUS; DIET; EXERCISE; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HEALTH PROGRAM; HUMAN; IMPAIRED GLUCOSE TOLERANCE; LIFESTYLE MODIFICATION; MAJOR CLINICAL STUDY; MALE; ORAL GLUCOSE TOLERANCE TEST; OUTCOME ASSESSMENT; OUTPATIENT CARE; PATIENT SATISFACTION; PHYSICAL ACTIVITY; WEIGHT CHANGE; WEIGHT REDUCTION;

EID: 84859859485     PISSN: 1530891X     EISSN: 19342403     Source Type: Journal    
DOI: 10.4158/EP11226.OR     Document Type: Article

References (40)

1. Nathan DM, Davidson MB, DeFronzo RA, et al (American Diabetes Association). Impaired fasting glucose and impaired glucose tolerance: Implications for care. Diabetes Care. 2007;30:753-759.
2. American Diabetes Association. Standards of medical care in diabetes-2011. Diabetes Care. 2011;34(suppl 1):S11-S61.
3. Centers for Disease Control and Prevention. 2011 National Diabetes Fact Sheet: Prediabetes Among People Aged 20 Years or Older, United States, 2010. http://www.cdc.gov/diabetes/pubs/estimates11.htm. Accessed for verification October 6, 2011.
4. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance: The Da Qing IGT and Diabetes Study. Diabetes Care. 1997;20:537-544.
5. Tuomilehto J, Lindström J, Eriksson JG, et al (Finnish Diabetes Prevention Study Group). Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med. 2001;344: 1343-1350.
6. Knowler WC, Barrett-Connor E, Fowler SE, et al (Diabetes Prevention Program Research Group). Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med. 2002;346: 393-403.
7. Ramachandran A, Snehalatha C, Mary S, Mukesh B, Bhaskar AD, Vijay V (Indian Diabetes Prevention Programme [IDPP]). The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1). Diabetologia. 2006;49:289-297.
8. Lindström J, Ilanne-Parikka P, Peltonen M, et al (Finnish Diabetes Prevention Study Group). Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: Follow-up of the Finnish Diabetes Prevention Study. Lancet. 2006;368:1673-1679.
9. Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: A 20-year follow-up study. Lancet. 2008;371:1783-1789.
10. Padwal R, Majumdar SR, Johnson JA, Varney J, McAlister FA. A systematic review of drug therapy to delay or prevent type 2 diabetes. Diabetes Care. 2005;28: 736-744.
11. DeFronzo RA, Tripathy D, Schwenke DC, et al (ACT NOW Study). Pioglitazone for diabetes prevention in impaired glucose tolerance. N Engl J Med. 2011;364: 1104-1115.
12. Zinman B, Harris SB, Neuman J, et al. Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): A double-blind randomised controlled study. Lancet. 2010;376:103-111.
13. Ackermann RT, Finch EA, Brizendine E, Zhou H, Marrero DG. Translating the Diabetes Prevention Program into the community: The DEPLOY Pilot Study. Am J Prev Med. 2008;35:357-363.
14. Seidel MC, Powell RO, Zgibor JC, Siminerio LM, Piatt GA. Translating the Diabetes Prevention Program into an urban medically underserved community: A nonrandomized prospective intervention study. Diabetes Care. 2008;31: 684-689.
15. Kramer MK, Kriska AM, Venditti EM, et al. Translating the Diabetes Prevention Program: A comprehensive model for prevention training and program delivery. Am J Prev Med. 2009;37:505-511.
16. Vanderwood KK, Hall TO, Harwell TS, Butcher MK, Helgerson SD (Montana Cardiovascular Disease and Diabetes Prevention Program Workgroup). Implementing a state-based cardiovascular disease and diabetes prevention program. Diabetes Care. 2010;33: 2543-2545.
17. Almeida FA, Shetterly S, Smith-Ray RL, Estabrooks PA. Reach and effectiveness of a weight loss intervention in patients with prediabetes in Colorado. Prev Chronic Dis. 2010;7:A103.
18. Vadheim LM, Brewer KA, Kassner DR, et al. Effectiveness of a lifestyle intervention program among persons at high risk for cardiovascular disease and diabetes in a rural community. J Rural Health. 2010;26:266-272.
19. Smith KJ, Hsu HE, Roberts MS, et al. Cost-effectiveness analysis of efforts to reduce risk of type 2 diabetes and cardiovascular disease in southwestern Pennsylvania, 2005-2007. Prev Chronic Dis. 2010;7:A109.
20. Katula JA, Vitolins MZ, Rosenberger EL, et al. One-year results of a community-based translation of the Diabetes Prevention Program: Healthy-Living Partnerships to Prevent Diabetes (HELP PD) Project. Diabetes Care. 2011;34:1451-1457.
21. Boltri JM, Davis-Smith YM, Seale JP, Shellenberger S, Okosun IS, Cornelius ME. Diabetes prevention in a faith-based setting: Results of translational research. J Public Health Manag Pract. 2008;14:29-32.
22. Laatikainen T, Dunbar JA, Chapman A, et al. Prevention of type 2 diabetes by lifestyle intervention in an Australian primary health care setting: Greater Green Triangle (GGT) Diabetes Prevention Project. BMC Public Health. 2007;7:249.
23. Absetz P, Oldenburg B, Hankonen N, et al. Type 2 diabetes prevention in the real world: Three-year results of the GOAL lifestyle implementation trial. Diabetes Care. 2009;32:1418-1420.
24. Saaristo T, Moilanen L, Korpi-Hyövälti E, et al. Lifestyle intervention for prevention of type 2 diabetes in primary health care: One-year follow-up of the Finnish National Diabetes Prevention Program (FIN-D2D). Diabetes Care. 2010;33:2146-2151.
25. Aldana SG, Barlow M, Smith R, et al. The diabetes prevention program: A worksite experience. AAOHN J. 2005;53:499-505.
26. McTigue KM, Conroy MB, Bigi L, Murphy C, McNeil M. Weight loss through living well: Translating an effective lifestyle intervention into clinical practice. Diabetes Educ. 2009;35:199-204, 208.
27. Centers for Disease Control and Prevention. National Diabetes Prevention Program, National Center for Chronic Disease Prevention and Health Promotion, Division of Diabetes Translation. http://www.cdc.gov/diabetes/proj ects/prevention-program.htm. Accessed for verification October 6, 2011.
28. Bersoux S, Asbury KL, Cook CB, et al. An outpatient-based clinical program for type 2 diabetes prevention. Endocr Pract. 2010;16:21-29.
29. Bersoux S, Cook CB, Wu Q, et al. Hemoglobin A1c testing alone does not sufficiently identify patients with prediabetes. Am J Clin Pathol. 2011;135:674-677.
30. Abdul-Ghani MA, Tripathy D, DeFronzo RA. Contributions of beta-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose. Diabetes Care. 2006;29: 1130-1139.
31. Abdul-Ghani MA, Jenkinson CP, Richardson DK, Tripathy D, DeFronzo RA. Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: Results from the Veterans Administration Genetic Epidemiology Study. Diabetes. 2006;55:1430-1435.
32. Wu RR, Zhao JP, Jin H, et al. Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: A randomized controlled trial. JAMA. 2008;299: 185-193.
33. Perreault L, Kahn SE, Christophi CA, Knowler WC, Hamman RF (Diabetes Prevention Program Research Group). Regression from pre-diabetes to normal glucose regulation in the Diabetes Prevention Program. Diabetes Care. 2009;32:1583-1588.
34. Hamman RF, Wing RR, Edelstein SL, et al. Effect of weight loss with lifestyle intervention on risk of diabetes. Diabetes Care. 2006;29:2102-2107.
35. Laaksonen DE, Lindström J, Tuomilehto J, Uusitupa M (Finnish Diabetes Prevention Study Group). Increased physical activity is a cornerstone in the prevention of type 2 diabetes in high-risk individuals. Diabetologia. 2007;50: 2607-2608.
36. Lindström J, Peltonen M, Eriksson JG, et al (Finnish Diabetes Prevention Study [DPS] Group). Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study. Diabetes Care. 2008;31: 857-862.
37. Abdul-Ghani MA, Williams K, DeFronzo R, Stern M. Risk of progression to type 2 diabetes based on relationship between postload plasma glucose and fasting plasma glucose. Diabetes Care. 2006;29:1613-1618.
38. Snehalatha C, Mary S, Selvam S, et al. Changes in insulin secretion and insulin sensitivity in relation to the glycemic outcomes in subjects with impaired glucose tolerance in the Indian Diabetes Prevention Programme-1 (IDPP-1). Diabetes Care. 2009;32:1796-1801.
39. Lorenzo C, Wagenknecht LE, D'Agostino RB Jr, Rewers MJ, Karter AJ, Haffner SM. Insulin resistance, beta-cell dysfunction, and conversion to type 2 diabetes in a multiethnic population: The Insulin Resistance Atherosclerosis Study. Diabetes Care. 2010;33:67-72.
40. Lipscomb ER, Finch EA, Brizendine E, Saha CK, Hays LM, Ackermann RT. Reduced 10-year risk of coronary heart disease in patients who participated in a community-based diabetes prevention program: The DEPLOY pilot study. Diabetes Care. 2009;32:394-396.